Direct Engagement of TLR4 in Invariant NKT Cells Regulates Immune Diseases by Differential IL-4 and IFN-γ Production in Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kim, Ji Hyung ^a,b   Kim, Hye Sung ^a   Kim, Hye Young ^a,b   Oh, Sae Jin ^a   Chung, Doo Hyun ^a  

^a Seoul National University College of Medicine   (South Korea)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ADOPTIVE TRANSFER; ALLERGIC PNEUMONITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; CELL INTERACTION; CELL STIMULATION; CELL SURFACE; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; DENDRITIC CELL; DETERIORATION; ENDOSOME; FLOW CYTOMETRY; IMMUNOPATHOLOGY; LUNG DISEASE; LUNG FIBROSIS; LYMPHOCYTE FUNCTION; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ALVEOLITIS, EXTRINSIC ALLERGIC; ANIMALS; ANTIGENS, CD1D; CELLS, CULTURED; ENDOCYTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; PULMONARY FIBROSIS; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84866561039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045348     Document Type: Article

References (50)

1. Lantz O, Bendelac A, (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180: 1097-1106.
2. Bendelac A, (1995) CD1: presenting unusual antigens to unusual T lymphocytes. Science 269: 185-186.
3. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, et al. (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 7: 1057-1062.
4. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, et al. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194: 1801-1811.
5. Kim HY, Kim HJ, Min HS, Kim S, Park WS, et al. (2005) NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production. J Exp Med 201: 41-47.
6. Cui J, Shin T, Kawano T, Sato H, Kondo E, et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
7. Kim JH, Kim HY, Kim S, Chung JH, Park WS, et al. (2005) Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am J Pathol 167: 1231-1241.
8. Dieli F, Taniguchi M, Kronenberg M, Sidobre S, Ivanyi J, et al. (2003) An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. J Immunol 171: 1961-1968.
9. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV, (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921-930.
10. Chen H, Paul WE, (1997) Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J Immunol 159: 2240-2249.
11. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H, (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21: 483-513.
12. Iwasaki A, Medzhitov R, (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
13. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
14. Takeda K, Kaisho T, Akira S, (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
15. Lu YC, Yeh WC, Ohashi PS, (2008) LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
16. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, et al. (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2: 947-950.
17. Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, et al. (2006) T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol 176: 7438-7446.
18. Re F, Strominger JL, (2001) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276: 37692-37699.
19. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB, (2002) Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J Immunol 168: 4524-4530.
20. Brigl M, Tatituri RV, Watts GF, Bhowruth V, Leadbetter EA, et al. (2011) Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 208: 1163-1177.
21. Tupin E, Kinjo Y, Kronenberg M, (2007) The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5: 405-417.
22. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, et al. (1999) The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189: 1121-1128.
23. Park Y, Kim HS, Ahn JY, Yun D, Cho ML, et al. (2010) IL-12p35 promotes antibody-induced joint inflammation by activating NKT cells and suppressing TGF-beta. J Immunol 185: 1476-1484.
24. Liew FY, Komai-Koma M, Xu D, (2004) A toll for T cell costimulation. Ann Rheum Dis 63 (Suppl 2):: ii76-ii78.
25. Gelman AE, Zhang J, Choi Y, Turka LA, (2004) Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 172: 6065-6073.
26. Gonzalez-Navajas JM, Fine S, Law J, Datta SK, Nguyen KP, et al. (2010) TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J Clin Invest 120: 570-581.
27. Kim S LS, Lee T, Jung S, Kim D, (2004) Practical synthesis of KRN7000 form phytosphingosine. Synthesis 22: 847-850.
28. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A, (1997) Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 272: 21597-21603.
29. Zheng W, Flavell RA, (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
30. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
31. Kagan JC, Su T, Horng T, Chow A, Akira S, et al. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9: 361-368.
32. Hwang SJ, Kim S, Park WS, Chung DH, (2006) IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils. J Immunol 177: 5258-5268.
33. Shimizu H, Matsuguchi T, Fukuda Y, Nakano I, Hayakawa T, et al. (2002) Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 123: 1265-1277.
34. Askenase PW, Itakura A, Leite-de-Moraes MC, Lisbonne M, Roongapinun S, et al. (2005) TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+ NKT cells to initiate contact sensitivity in vivo. J Immunol 175: 6390-6401.
35. Nagarajan NA, Kronenberg M, (2007) Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 178: 2706-2713.
36. Hornef MW, Normark BH, Vandewalle A, Normark S, (2003) Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198: 1225-1235.
37. Uronen-Hansson H, Allen J, Osman M, Squires G, Klein N, et al. (2004) Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111: 173-178.
38. Hassan F, Islam S, Tumurkhuu G, Naiki Y, Koide N, et al. (2006) Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide. BMC Cancer 6: 281.
39. Thieblemont N, Wright SD, (1999) Transport of bacterial lipopolysaccharide to the golgi apparatus. J Exp Med 190: 523-534.
40. Beatty WL, Meresse S, Gounon P, Davoust J, Mounier J, et al. (1999) Trafficking of Shigella lipopolysaccharide in polarized intestinal epithelial cells. J Cell Biol 145: 689-698.
41. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
42. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB, (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230-1237.
43. Dieli F, Sireci G, Russo D, Taniguchi M, Ivanyi J, et al. (2000) Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med 192: 1645-1652.
44. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, et al (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
45. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986.
46. Bendelac A, Savage PB, Teyton L (2006) The Biology of NKT Cells. Annu Rev Immunol.
47. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, et al. (2004) TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 173: 7070-7077.
48. Liu B, Yang Y, Dai J, Medzhitov R, Freudenberg MA, et al. (2006) TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol 177: 6880-6888.
49. Choe JY, Crain B, Wu SR, Corr M, (2003) Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med 197: 537-542.
50. Bauer AK, Dixon D, DeGraff LM, Cho HY, Walker CR, et al. (2005) Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis. J Natl Cancer Inst 97: 1778-1781.